Drug Pipeline News

>

Latest News

FDA expands label for lipid injectable emulsion to preterm and term neonates | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA expands label for lipid injectable emulsion to preterm and term neonates

May 15th 2024

Approximately 40% of patients who receive PN in the United States as an intravenous source of nourishment are under 18 years of age.

FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years

May 13th 2024

FDA approves ALTUVIIIO updated label for bleed protection in children with hemophilia | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves ALTUVIIIO updated label for bleed protection in children with hemophilia

May 13th 2024

DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
DB-OTO improved hearing to normal in child with profound genetic deafness

May 8th 2024

Nirsevimab reduced RSV hospitalizations in infants by 82%, new data shows | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.
Nirsevimab reduced RSV hospitalizations in infants by 82%, new data show

May 2nd 2024

Video Interviews
Latest CME Events & Activities

Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing

View More

Shaping the Management of COPD with Biologic Therapy

View More

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology

View More

Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

More News

© 2024 MJH Life Sciences

All rights reserved.